EssilorLuxottica to acquire PUcore’s division dedicated to the development, manufacturing and sale of ophthalmic lens materials

Core Insights - EssilorLuxottica has signed an agreement to acquire PUcore's division focused on the development, manufacturing, and sale of ophthalmic lens materials, enhancing its R&D and production capabilities for innovative high index lenses [1][2] - The acquisition includes a research and development unit, a materials production facility, and a sales office in South Korea, along with an intellectual property portfolio related to product formulations and production processes [2][3] - The transaction is expected to close by the end of 2025, pending regulatory approvals and customary closing conditions [4] Company Strategy - The acquisition aligns with EssilorLuxottica's commitment to improving standards in the research, development, and manufacturing of ophthalmic lenses, allowing the company to expand its portfolio of patents, technologies, and expertise [3] - By enhancing the production and formulation of high index monomers, the company aims to improve performance and sustainability across the ophthalmic industry [3]